References
- Skyler JS. Relationship of metabolic control of diabetes mellitus to chronic complications. In: Ellenberg M, Rifkin H, Pone D, eds. Diabetes mellitus: theory and practice. 4th ed. New York: Elsevier Science Publishing, 1990: 856–68
- Hirsch IB, Farkas-Hinch R, Skyier JS. Intensive insulin therapy for the treatment of type I diabetes mellitus. Diabetes Care 1990: 13(12): 1265–83
- Landon MB, Gabbe SG. Diabetes and pregnancy. Med Clin North Am 1988: 72(6): 1493–511
- Davis M. Diabetic retinopathy. (Editorial) Int Ophthalmol Clin 1987: 27(4): 223–334
- Viberti GC, Walker JD. Diabetic nephropathy: etiology and prevention. Diabetes Metab Rev 1988: 4(2): 147–62
- Skyler JS. Insulin-dependent diabetes mellitus: flexibility in contemporary management. Postgrad Med 1987: 81(6): 163–9, 172–4
- Selam JL, Charles MA. Devices for insulin administration. Diabetes Care 1990: 13(9): 955–79
- Shichiri M, Kawamori R, Hakui N, et al. Closed-loop glycemic control with a wearable artificial endocrine pancreas: variations in daily insulin requirements to glycemic response. Diabetes 1984: 33(12): 1200–2
- Brange J, Owens DR, Kang S, et al. Monomeric insulins and their experimental and clinical implications. Diabetes Care 1990: 13(9): 923–54
- Jorgensen S, Vaag A, Langkjaer L, et al. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue. BMJ 1989: 299(6696): 415–9
- Drejer K, Vaag A, Bech K, et al. Pharmacokinetics of intranasally administered insulin with phospholipid as absorption enhancer. Diabetologia 1990: 33(Suppl 1): A61
- Sutherland DE, Moudry KC, Fryd DS. Results of pancreas-transplant registry. Diabetes 1989: 38(Suppl 1): 46–54
- Selden RF, Skoskiewicz MJ, Russdl PS, et al. Regulation of insulin-gene expression: implications for gene therapy. N Engl J Med 1987: 317(17): 1067–76
- Skyler JS, Rabinovitch A. Etiology and pathogenesis of insulin dependent diabetes mellitus. Pediatr Ann 1987: 16(9): 682–3, 686–92
- Marks JB, Skyler JS. Clinical review: immunotherapy of type I diabetes mellitus. J Clin Endocrinol Metab 1991: 72(1): 3–9
- American Diabetes Association Ad Hoc Expert Committee. Prevention of type I diabetes mellitus Diabetes 1990: 39(9): 1151–2; Diabetes Care 1990: 13(9): 1026–7
- The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 1987: 10(1): 1–19
- Brownlee M, Sherwood LM, eds. Diabetes mellitus and its complications: pathogenesis and treatment. Philadelphia: Hanley & Belfus, 1990
- Brownlee M, Cerami A, Vlassara H. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 1988: 4(5): 437–51
- Kinoshita JH, Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 1988: 4(4): 323–37
- Greene DA, Lattimer SA, Sima AA. Pathogenesis and prevention of diabetic neuropathy. Diabetes Metab Rev 1988: 4(3): 201–21
- Anderson S, Brenner BM. Pathogenesis of diabetic glomerulopathy: hemodynamic considerations. Diabetes Metab Rev 1988: 4(2): 163–77
- Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987: 3(2): 463–524
- Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989: 149(7): 1514–20br
- Donahue RP, Skyler JS, Schneiderman N, et al. Hyperinsulinemia and elevated blood pressure: cause, confounder, or coincidence? Am J Epidemiol 1990: 132(5): 827–36